SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

CVS Health Corp. – ‘10-Q’ for 6/30/23 – ‘EX-10.1’

On:  Wednesday, 8/2/23, at 6:36am ET   ·   For:  6/30/23   ·   Accession #:  64803-23-33   ·   File #:  1-01011

Previous ‘10-Q’:  ‘10-Q’ on 5/3/23 for 3/31/23   ·   Next:  ‘10-Q’ on 11/1/23 for 9/30/23   ·   Latest:  ‘10-Q’ on 5/1/24 for 3/31/24   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/02/23  CVS Health Corp.                  10-Q        6/30/23  104:18M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   3.53M 
 2: EX-10.1     Material Contract                                   HTML     47K 
 3: EX-10.2     Material Contract                                   HTML    203K 
 4: EX-15.1     Letter re: Unaudited Interim Financial Info         HTML     28K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     33K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     33K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     30K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     30K 
14: R1          Cover Page                                          HTML     81K 
15: R2          Condensed Consolidated Statements of Operations     HTML    142K 
                (Unaudited)                                                      
16: R3          Condensed Consolidated Statements of Comprehensive  HTML     73K 
                Income (Unaudited)                                               
17: R4          Condensed Consolidated Balance Sheets (Unaudited)   HTML    179K 
18: R5          Condensed Consolidated Balance Sheets (Unaudited)   HTML     51K 
                (Parenthetical)                                                  
19: R6          Condensed Consolidated Statements of Cash Flows     HTML    135K 
                (Unaudited)                                                      
20: R7          Condensed Consolidated Statements of Shareholders'  HTML    150K 
                Equity (Unaudited)                                               
21: R8          Condensed Consolidated Statements of Shareholders'  HTML     35K 
                Equity (Parenthetical)                                           
22: R9          Condensed Consolidated Statements of Cash Flows     HTML     30K 
                (Unaudited) (Parenthetical)                                      
23: R10         Significant Accounting Policies                     HTML    300K 
24: R11         Acquisition and Assets Held for Sale                HTML    111K 
25: R12         Restructuring Program                               HTML     32K 
26: R13         Investments                                         HTML    329K 
27: R14         Fair Value                                          HTML    152K 
28: R15         Health Care Costs Payable                           HTML     55K 
29: R16         Other Insurance Liabilities and Separate Accounts   HTML    163K 
30: R17         Borrowings                                          HTML    100K 
31: R18         Shareholders' Equity                                HTML     44K 
32: R19         Other Comprehensive Income (Loss)                   HTML    102K 
33: R20         Earnings Per Share                                  HTML     54K 
34: R21         Commitments and Contingencies                       HTML     81K 
35: R22         Segment Reporting                                   HTML    223K 
36: R23         Pay vs Performance Disclosure                       HTML     41K 
37: R24         Insider Trading Arrangements                        HTML     35K 
38: R25         Significant Accounting Policies (Policies)          HTML     96K 
39: R26         Significant Accounting Policies (Tables)            HTML    278K 
40: R27         Acquisition and Assets Held for Sale (Tables)       HTML    107K 
41: R28         Investments (Tables)                                HTML    340K 
42: R29         Fair Value (Tables)                                 HTML    168K 
43: R30         Health Care Costs Payable (Tables)                  HTML     54K 
44: R31         Other Insurance Liabilities and Separate Accounts   HTML    194K 
                (Tables)                                                         
45: R32         Borrowings (Tables)                                 HTML     95K 
46: R33         Shareholders' Equity (Tables)                       HTML     35K 
47: R34         Other Comprehensive Income (Loss) (Tables)          HTML    101K 
48: R35         Earnings Per Share (Tables)                         HTML     52K 
49: R36         Segment Reporting (Tables)                          HTML    219K 
50: R37         Significant Accounting Policies - Narrative         HTML     93K 
                (Details)                                                        
51: R38         Significant Accounting Policies - Cash and Cash     HTML     40K 
                Equivalents, Restricted Cash and Cash Equivalents                
                (Details)                                                        
52: R39         Significant Accounting Policies - Accounts          HTML     45K 
                Receivable (Details)                                             
53: R40         Significant Accounting Policies - Deferred          HTML     39K 
                Acquisition Costs (Details)                                      
54: R41         Significant Accounting Policies - Disaggregation    HTML    103K 
                of Revenue (Details)                                             
55: R42         Significant Accounting Policies - Receivables and   HTML     34K 
                Contracted Balances (Details)                                    
56: R43         Significant Accounting Policies - Contract          HTML     39K 
                Balances (Details)                                               
57: R44         Significant Accounting Policies - New Accounting    HTML     68K 
                Pronouncements Recently Adopted (Details)                        
58: R45         Significant Accounting Policies - Changes in        HTML     72K 
                balances of long-duration insurance liabilities                  
                (Details)                                                        
59: R46         Significant Accounting Policies - Adjustments       HTML    227K 
                Resulting From Applying New Accounting Standard                  
                (Details)                                                        
60: R47         Acquisition and Assets Held for Sale - Narrative    HTML     66K 
                (Details)                                                        
61: R48         Acquisition and Assets Held for Sale - Schedule of  HTML     51K 
                Fair Value of Consideration Transferred (Details)                
62: R49         Acquisition and Assets Held for Sale - Schedule of  HTML     90K 
                Estimated Fair Values of Assets Acquired and                     
                Liabilities Assumed (Details)                                    
63: R50         Acquisition and Assets Held for Sale - Summary of   HTML     48K 
                the Preliminary Valuation of Goodwill Allocated to               
                Business Segments (Details)                                      
64: R51         Acquisition and Assets Held for Sale - Summary of   HTML     50K 
                Preliminary Fair Values and Weighted Average                     
                Useful Lives for Intangible Assets Acquired                      
                (Details)                                                        
65: R52         Acquisition and Assets Held for Sale - Summary of   HTML     61K 
                Assets and Liabilities Held for Sale (Details)                   
66: R53         Restructuring Program (Details)                     HTML     38K 
67: R54         Investments - Total Investment Schedule (Details)   HTML     45K 
68: R55         Investments - Debt Securities (Details)             HTML     82K 
69: R56         Investments - Debt Securities by Maturity           HTML     72K 
                (Details)                                                        
70: R57         Investments - Unrealized Loss Position (Details)    HTML    105K 
71: R58         Investments - Unrealized Loss Position Maturities   HTML     92K 
                (Details)                                                        
72: R59         Investments - Mortgage Loans (Details)              HTML     36K 
73: R60         Investments - Mortgage Loans Credit Ratings         HTML     78K 
                Indicator (Details)                                              
74: R61         Investments - Net Investment Income (Details)       HTML     54K 
75: R62         Investments - Realized Gains (Details)              HTML     36K 
76: R63         Fair Value - Measurement on a Recurring Basis       HTML    111K 
                (Details)                                                        
77: R64         Fair Value - Narrative (Details)                    HTML     31K 
78: R65         Fair Value - Carrying Value and Fair Value          HTML     60K 
                Classified by Level (Details)                                    
79: R66         Fair Value - Separate Accounts Fair Value           HTML     69K 
                (Details)                                                        
80: R67         Health Care Costs Payable - Components of Change    HTML     72K 
                in Health Care Costs Payable (Details)                           
81: R68         Health Care Costs Payable - Narrative (Details)     HTML     35K 
82: R69         Other Insurance Liabilities and Separate Accounts   HTML    108K 
                - Changes in Liability for Future Policy Benefits                
                (Details)                                                        
83: R70         Other Insurance Liabilities and Separate Accounts   HTML     38K 
                - Undiscounted Expected Gross Premiums and                       
                Expected Future Benefit Payments (Details)                       
84: R71         Other Insurance Liabilities and Separate Accounts   HTML     40K 
                - Weighted-average Interest Rates and Durations                  
                (Details)                                                        
85: R72         Other Insurance Liabilities and Separate Accounts   HTML     53K 
                - Roll Forward of Policyholders' Funds (Details)                 
86: R73         Other Insurance Liabilities and Separate Accounts   HTML     68K 
                - Separate Account Assets (Details)                              
87: R74         Other Insurance Liabilities and Separate Accounts   HTML     49K 
                - Roll Forward of Separate Accounts (Details)                    
88: R75         Borrowings - Schedule of Borrowings (Details)       HTML    188K 
89: R76         Borrowings - Narrative (Details)                    HTML    106K 
90: R77         Shareholders' Equity - Share Repurchases (Details)  HTML     45K 
91: R78         Shareholders' Equity - Accelerated Share            HTML     55K 
                Repurchases (Details)                                            
92: R79         Shareholders' Equity - Dividends (Details)          HTML     30K 
93: R80         Other Comprehensive Income (Loss) (Details)         HTML    137K 
94: R81         Earnings Per Share (Details)                        HTML     69K 
95: R82         Commitments and Contingencies (Details)             HTML     65K 
96: R83         Segment Reporting - Narrative (Details)             HTML     31K 
97: R84         Segment Reporting - Retrospective Adjustments to    HTML     76K 
                Segment Composition (Details)                                    
98: R85         Segment Reporting - Reconciliation of Financial     HTML     74K 
                Measures of Segments to Consolidated Totals                      
                (Details)                                                        
99: R86         Segment Reporting - Reconciliation of Consolidated  HTML     61K 
                Operating Income to Adjusted Operating Income                    
                (Details)                                                        
102: XML         IDEA XML File -- Filing Summary                      XML    189K  
100: XML         XBRL Instance -- cvs-20230630_htm                    XML   5.60M  
101: EXCEL       IDEA Workbook of Financial Report Info              XLSX    268K  
10: EX-101.CAL  XBRL Calculations -- cvs-20230630_cal                XML    356K 
11: EX-101.DEF  XBRL Definitions -- cvs-20230630_def                 XML   1.19M 
12: EX-101.LAB  XBRL Labels -- cvs-20230630_lab                      XML   2.69M 
13: EX-101.PRE  XBRL Presentations -- cvs-20230630_pre               XML   1.72M 
 9: EX-101.SCH  XBRL Schema -- cvs-20230630                          XSD    264K 
103: JSON        XBRL Instance as JSON Data -- MetaLinks              722±  1.09M  
104: ZIP         XBRL Zipped Folder -- 0000064803-23-000033-xbrl      Zip    642K  


‘EX-10.1’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  
Exhibit 10.1
ESPP AMENDMENT
CVS HEALTH CORPORATION

INTERNATIONAL EMPLOYEE STOCK PURCHASE PLAN
(SUB-PLAN OF THE CVS HEALTH CORPORATION 2007 EMPLOYEE STOCK
PURCHASE PLAN)


The following constitutes the provisions of the International Employee Stock Purchase Plan (herein called the “Sub-Plan”), a sub-plan of the CVS Health Corporation (the “Company”) 2007 Employee Stock Purchase Plan, as it may be amended and restated from time to time (the “Plan”).

1.    Purpose.
The purpose of this Sub-Plan is to assist Eligible Employees of the Company’s Designated Non-U.S. Subsidiaries (as defined herein) with an opportunity to purchase shares of Stock of the Company through accumulated payroll deductions, enabling such persons to acquire or increase a proprietary interest in the Company in order to strengthen the mutuality of interests between such persons and the Company’s stockholders, and to provide a benefit that will assist the Company in competing to attract and retain employees of high quality. The Sub-Plan is implemented in accordance with Sections 13 and 19 of the Plan.
2.    Non-Qualification. The Sub-Plan is not intended to qualify as an employee stock purchase plan under Section 423(b) of the U.S. Internal Revenue Code of 1986, as amended. Grants of option to purchase shares of Stock under the Sub-Plan are not intended to be Section 423(b) qualified offerings, and shall be deemed separate from the grant of option to purchase shares of Stock under the Plan with respect to equal rights and privileges for purposes of preserving the Plan’s Section 423 (b) qualification.

3.    Governing Terms. All provisions of this Sub-Plan shall be governed by the Plan, except as otherwise provided herein.

4.    Effective Date. This Sub-Plan shall be effective from the date of its adoption by the Board or Administrator.

5.    Definitions.    All definitions in the Sub-Plan shall be interpreted in accordance with the Plan except as otherwise provided herein:

(a)    “Designated Non-U.S. Subsidiary” shall mean any Subsidiary located outside of the United States that is identified by the Administrator in Appendix A hereto as appropriate for participation in the Sub-Plan.

(b)    “Eligible Employee” shall mean any person employed by a Designated Non-U.S. Subsidiary, subject to Section 6 of this Sub-Plan below.



Proprietary
1


6.    Eligibility. Each individual who is an Eligible Employee on the applicable eligibility cutoff date (determined by the Company) prior to the start of the next Offering Period shall be eligible to participate in the Sub-Plan, provided, however, that the restrictions under the definition of Eligible Employee in Section 3 of the Plan shall not apply for purposes of determining Eligible Employees under the Sub-Plan.

7.    Participation. An Eligible Employee shall become a participant in the Sub-Plan once they have completed the steps and requirements outlined in Section 5 of the Plan.

8.    Payroll Deductions and Other Approved Contributions.

(a)    Except to the extent otherwise determined by the Administrator, payroll deductions shall be made in accordance with Section 6 of the Plan. The Administrator may, at its discretion, approve other methods for contributions including, without limitation, check, money wire, cash, or standing order of the participant’s individual bank account.

(b)     The amounts so collected shall be credited to the participant’s individual book account under the Sub-Plan, initially in the currency in which paid by the Designated Non-U.S. Subsidiary until converted into U.S. Dollars. Accordingly, all purchases of shares of Stock under the Sub-Plan are to be made with U.S. Dollars into which the payroll deductions for the offering or other approved contributions have been converted. The amounts collected from a participant may be commingled with the general assets of the Company or the Designated Non-U.S. Subsidiary and may be used for general corporate purposes, except as otherwise required by applicable law.

(c)    For purposes of determining the number of shares of Stock purchasable by a participant, the payroll deductions or other approved contributions credited to each participant’s book account during each Offering Period shall be converted into U.S. Dollars on or shortly prior to the end of that Purchase Period on the basis of the exchange rate determined by the Company. The Administrator shall have the absolute discretion to determine the applicable exchange rate to be in effect for each end of an Offering Period by any reasonable method.

9.    Exercise of Option. Exercise of the option shall be in accordance with Section 8 of the Plan.

10.    Withdrawal or Termination of Employment.    Withdrawal from the Sub-Plan or ceasing to be an Eligible Employee shall be in accordance with Section 10 of the Plan, subject to Section 11 of this Sub-Plan below.

11.    Transfer of Employment.

(a)    In the event that a participant who is an Eligible Employee of a Designated Non- U.S. Subsidiary is transferred and becomes an employee of a different Designated Non-U.S. Subsidiary during an Offering Period, such individual may, subject to the terms and eligibility of this Sub-Plan, remain a participant under this Sub-Plan for the duration of the Offering Period in effect at that time. Unless otherwise required under applicable law, any payroll deductions or other
Proprietary
2


approved contributions may continue to be held by the Designated Non-U.S. Subsidiary former employer of the participant for the remainder of the Offering Period. At the last day of such Offering Period, all payroll deductions and other approved contributions made by or to such former employer Designated Non-U.S. Subsidiary and/or the current employer Designated Non-U.S. Subsidiary shall be aggregated for the purchase of shares of Stock subject to the terms and limitations of the Sub-Plan.

(b)    In the event that an employee of the Company or a Subsidiary in the U.S. is an Eligible Employee who has authorized payroll deductions under the Plan with respect to an Offering Period in effect under the Plan and becomes an employee of a Designated Non-U.S. Subsidiary during such Offering Period, the employee may become a participant under the Sub- Plan for the remainder of such Offering Period. Unless otherwise required under applicable law, any payroll deductions may continue to be held by the former employer Company or designated Subsidiary in the U.S. for the remainder of the Offering Period. At the last day of such Offering Period, all payroll deductions and other approved contributions made to the Company or Subsidiary and the employing Designated Non-U.S. Subsidiary may be aggregated for the purchase of shares of Stock subject to the terms and limitations of the Plan and the Sub-Plan.
12.    Interest. Contributions received or held pursuant to the Sub-Plan shall accrue interest only to the extent required under applicable law.
13.    Shares Subject to the Sub-Plan.

(a)    The shares of Stock purchasable by participants under the Sub-Plan shall be made available from shares reserved under Section 12 of the Plan and any shares of Stock issued under the Sub-Plan will reduce, on a share-for-share basis, the number of shares of Stock available for subsequent issuance under the Plan.

(b)    The participant will have no interest or voting right in shares of Stock covered by his or her rights to purchase shares until such rights have been exercised and shares have been issued.

14.    Administration. The Sub-Plan shall be administered in accordance with Section 13 of the Plan. The Administrator may adopt rules or procedures relating to the operation and administration of the Sub-Plan to accommodate the specific requirements of the law and procedures of applicable jurisdictions. Without limiting the generality of the foregoing, the Administrator is specifically authorized to adopt rules and procedures regarding the handling of payroll deductions or other approved contributions, segregation of funds, payment of interest, conversion of local currency, payroll tax, withholding procedures and issuance of shares that vary with local requirements. The Administrator may also adopt rules, procedures or sub-plans applicable to particular Designated Non-U.S. Subsidiaries or jurisdictions. The rules of such sub-plans may take precedence over other provisions of this Sub-Plan, but unless otherwise superseded by the terms of such sub-plan, the provisions of this Sub-Plan shall govern the operation of such sub-plan.
15.    Transferability. Neither payroll deductions nor other funds credited to a participant’s account nor any rights with regard to the exercise of an option or to receive shares of Stock under
Proprietary
3


this Sub-Plan may be assigned, transferred, pledged, or otherwise disposed of in any way (other than through designation of beneficiary procedures as provided in the Plan) by the participant. In order to comply with applicable law (including, without limitation, local securities, and applicable exchange laws), the Company may require a participant to retain the shares of Stock purchased on his or her behalf in a Company account or an account of a designated broker until the sale of such shares.

16.    Amendment or Termination. The Administrator may at any time terminate or amend this Sub-Plan. No such termination can affect options previously granted, nor may an amendment make any change in any option theretofore granted which adversely affects the rights of any participant. Notwithstanding any provision of the Plan or this Sub-Plan to the contrary, in order to comply with the laws in other countries in which the Company and the Designated Non-U.S. Subsidiaries operate or have participants, the Company, by the action of its duly authorized officers, in their sole discretion, shall have the power and authority at any time to establish “offering documents” and similar addenda to this Sub-Plan to modify administrative procedures and other terms and procedures, to the extent such actions may be necessary or advisable and take any action that it deems advisable to obtain approval or comply with any necessary local governmental regulatory exemptions or approvals. Notwithstanding the foregoing, no action may be taken hereunder that would violate any securities law or governing statute or any other applicable law or cause the Plan not to comply with Section 423 of the Code.

17.    Notices. All notices or other communications by an Eligible Employee or participant to the Company under or in connection with the Sub-Plan shall be deemed to have been duly given when received in the form specified by the Company at the location, or by the person, designated by the Company for the receipt thereof.

18.    Term of Sub-Plan. The Sub-Plan shall continue in effect until the expiration or termination of the Plan or the earlier termination of the Sub-Plan by the Administrator.

19.    No Additional Employment Rights. Neither the action of the Company in establishing the Sub-Plan, nor any action taken under the Sub-Plan by the Administrator, nor any provision of the Sub-Plan itself shall be construed so as to grant any person the right to remain in the employment of the Company or any Designated Non-U.S. Subsidiary for any period of specific duration, and such person’s employment may be terminated at any time, with or without cause, subject to applicable law.

20.    Foreign Exchange Risk. Any changes or fluctuations in the exchange rate at which the payroll deductions or other approved contributions collected on the participant’s behalf are converted into U.S. Dollars in connection with each purchase of shares shall be borne solely by the participant. Neither the Company nor any Designated Non-U.S. Subsidiary shall bear any exchange rate or foreign exchange risk in connection with the Sub-Plan.

Proprietary
4


APPENDIX A

DESIGNATED NON-U.S. SUBSIDIARIES



SIGNIFY IRELAND TECHNOLOGY DEVELOPMENT LIMITED



Proprietary
5

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/07/24  CVS Health Corp.                  10-K       12/31/23  166:28M


1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/02/23  CVS Health Corp.                  8-K:8,9     6/02/23   16:494K                                   Donnelley … Solutions/FA
Top
Filing Submission 0000064803-23-000033   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 8:25:56.1pm ET